HPV Vaccination in the Asian and Pacific Region; Achievements and Barriers

APJCP's Authors Scientific Symposium, June 21st, 2025




Rationales and Objectives

The increasing prevalence of human papillomavirus (HPV)-related cancers, particularly cervical cancer, remains a pressing public health issue across Asia and the Pacific. According to the World Health Organization (WHO), cervical cancer is the fourth most common cancer in women globally, with a disproportionate burden in low- and middle-income countries (LMICs), many of which are located in the Asia-Pacific region. Despite the availability of safe and effective vaccines, uptake remains uneven due to systemic, cultural, logistical, and political barriers.

In this context, the Asian Pacific Journal of Cancer Prevention (APJCP) and the Asian Pacific Organization for Cancer Prevention (APOCP) have jointly taken the initiative to host a hybrid symposium titled “HPV Vaccination in the Asian and Pacific Region: Achievements and Barriers” on June 21, 2025. This event seeks to serve as a strategic meeting point for researchers, public health practitioners, policy makers, and advocates who are dedicated to the prevention and control of HPV-related cancers.

Why This Symposium Now?

Several pivotal reasons drive the urgency of this event:

1. Unequal Access to HPV Vaccination
2. Global Health Goals and WHO Elimination Strategy
3. APJCP’s Contribution to HPV Research
4. Collaborative Policy Making and Best Practices

Symposium Objectives

– Highlight Regional Achievements
– Identify and Discuss Barriers
– Strengthen Collaboration and Knowledge Exchange
– Produce a Knowledge-Based Output

The Scientific Committee

 

Prof. Nirmala Bhoo Pathy President, 13th APOCP General Assembly, Malaysia

 Prof. Murat Gultekin

Sağlık Bakanlığı-Turkish Ministry of Health, Turkiye 

Prof. Youlin Qiao

 Chinese Academy of Medical Sciences, China

Dr. Abhishek Shankar

Radiation Oncology Dept, All India Institute of Medical Sciences, India

Dr.  Philip Davies 

Director General – International Cervical Cancer Prevention Association

.

Dr. Tsetsegsaikhan Batmunkh 

Founder & CEO, National Cancer Council of Mongolia, Mongolia.


 

Dr. Alfiya Shamsutdinova,

Kazakh National Medical University, Kazakhstan


Dr. Alireza Mosavi Jarrahi Shahid Beheshti University of Medical Sciences, Iran

Dr Dipanwita Banerjee

Gynaecological Oncology, Chittaranjan National Cancer Institute, Kolkata, India

Dr. Maqsood Siddiqi

Cancer Foundation of India, India

Dr. Gambhir Shrestha

Institute of Medicine, Kathmandu, Nepal

Dr. Soewarta Kosen

International Health Independent Consultant, Jakarta, Indonesia

Dr. Anotone Barchak

Petrov Research Institute of Oncology, Russia

Dr. Suleeporn Sangrajrang

National Cancer Institute, Bangkok, Thailand

Prof. Dr. shamsul azhar shah

Faculty of Medicine
University Kebangsaan Malaysia

Prof. Nurbek Igissinov

Central Asian Cancer Institute,
Astana Kazakhstan.

Prof. Elsayed I. Salim

Tanta University, Tanta, Egypt


Prof. Alisher KahharovMedical Radiology Department of Tashkent, Uzbekistan
      

Symposium modulator:


   

Aram Halimi. MSc in Epidemiology

Research Center for Social Determinants of Health, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

 

 

.


Young Investigator Awards

In order to encourage young investigators to present their research, there will be two awards of 300 US dollars to be given to three young scientists with the best presentation. A panel of experts who constitute the prize committee will decide on selecting the candidate for the prize. The candidate will be selected from those who present their research live at the meeting. The decision about the candidate will be announced at the closing ceremony on the last day of the event.

The Young Investigator Awards are supported by the APOCP’s West Asia Chapter.

West Asia Organization for Cancer Prevention (WAOCP), APOCP’s West Asia Chapter

Participation in the Meeting

There will be two categories of scientists who want to participate:

  1. Participants who want to have a live presentation at the symposium.  These participants need to send an abstract for the meeting.  The abstract will be evaluated and decided on. Abstracts accepted for oral presentation will have the chance to present live online in one of the sessions. Accepted abstracts must be presented during the session and already have their slides prepared and sent to the organizing committee for preparation. The details on how to prepare the presentation will be sent to the applicant later. To send an abstract, please click on this link, register, and then you will be prompted for abstract submission.

All the accepted abstracts will be published and received DOI as the symposium abstract book. 

  1. Participants who just want to participate but have no presentation. This category of participant must register for the meeting to participate.  There is no registration fee for participation. Each session is limited to 100 participants.  Due to technical limitations, the first-come, first-served strategy will be applied. The first comers are those who register for the meeting earlier. To register,  please click on this link.




HPV Vaccination in the Asian and Pacific Region: Achievements and Barriers

APJCP’s Authors Symposium

Date: June 21, 2025. Time: 4:00 PM – 8:10 PM Beijing Time (UTC+8). Format: Online

Time

Speaker

Affiliation / Country

Title

16:00 – 16:10

Dr. Alireza Mosavi Jarrahi

Editor in Chief, Asian Pacific Journal of Cancer Prevention,

 

APJCP (a hub of info. in HPV vaccination in Asia)

16:10 – 16:25

Prof. You Lin Qiao

Chinese Academy of Medical Sciences,

APOCP Executive Committee Member, China

HPV Vaccination in China

16:25 – 16:55

Dr. Philip Davies

Key Note Speaker

 International Cervical Cancer Prevention Association,

Nicolae Testemițanu University, Moldova

HPV Vaccination Across Eastern Europe and Central Asia

16:50 – 17:10

Dr. Soewarta Kosen

Health Systems Specialist, Indonesia

HPV Vaccination Achievement and Challenges: Experience of Indonesia

17:10 – 17:30

Dr. Dipanwita Banerjee

Chittaranjan National Cancer Institute, India

National and International HPV Vaccination Programs with Special Reference to LMICs

17:30 – 17:40

Break (10 minutes)

17:40 – 18:00

Dr. Gambhir Shrestha

Institute of Medicine, Nepal

Implementation of HPV Vaccination in Nepal: A Milestone in Cervical Cancer Prevention

18:00 – 18:15

Dr. Yasir Abdulateef

Medical School / University of Anbar FIBMS / Pathology Subspecialty Clinical Microbiology and Immunity, Iraq.

HPV Vaccination in Iraq

18:15 – 18:30

Dr. A. Elvira

A. K. Akhunbaev Kyrgyz State Medical Academy

HPV Vaccination in Kyrgyzstan

18:30 – 18:45

Dr. A.Shankar

All India Institute of Medical Sciences, India

HPV Vaccination in India

18:45 – 18:55

Break (10 minutes)

18:55 – 19:10

Dr. Tsetsegsaikhan Batmunkh

Founder & CEO, National Cancer Council of Mongolia

HPV Vaccination in Mongolia

19:10 – 19:25

Dr. Nimala B. Pathy

President, the 13th APOCP General Assembly, Malaysia

HPV Vaccination in Malaysia

19:25 – 19:40

Dr. Shavkat Abdusattorov

Tashkent Pediatric Medical Institute, Uzbekistan

HPV Vaccination in Uzbekistan

19:40 – 19:55

Dr. Alfiya Shamsutdinova

Kazakh National Medical University, Kazakhstan

Implementing HPV Vaccination Programs for Adolescent Girls in Kazakhstan: Challenges and Opportunities

19:55 – 20:10

Miss. Shakila Sharifian

Shahid Beheshti University of Medical Sciences, Tehran Iran

Knowledge and Attitude and Awareness of HPV Vaccination Among Asian Healthcare Workers

20:10 – 20:20

Mr. A. Halimi, MS. Mohammad Sadegh Nematollahi

Department of Health Policy and Management, School of Public Health and Safety, Shahid Beheshti U. of Medical Sciences, Iran

Managerial Barriers to Implementing HPV Screening Programs in Iran: A Narrative Literature Review